Latest News

  • February 10, 2014

    Phase II Clinical Trial For Cystic Fibrosis

    AIT’s Phase II Clinical Trial for Cystic Fibrosis Adds Schneider Children’s Medical Center of Israel as Second Site in Expanded …

    Read more

  • February 3, 2014

    AIT To Present NOxCureBR

    AIT To Present NOxCureBR at the Annual Meeting of the Israeli Association of Clinical Pediatrics (Israeli clinical Pediatric Society 2014)

    Read more

  • January 23, 2014

    AIT To Present Phase II Clinical Data For NOxCureBR

    AIT To Present Phase II Clinical Data for NOxCureBR, A Treatment for Acute Bronchiolitis and RSV in infants

    Read more

  • January 7, 2014

    AIT Announces Phase II Study Of NOxCureCF

    AIT Announces Phase II Study of NOxCureCF, a Respiratory Treatment for Cystic Fibrosis Patients Using a Nitric Oxide-Base Formulation Enrollment …

    Read more

  • December 16, 2013

    Hannah Blau, M.B.B.S, Joins AIT’s Scientific Advisory Board

    Rehovot, Israel – 16 December 2013 – Advanced Inhalation Therapies (AIT), a leader in the development of innovative therapeutics for …

    Read more

  • September 17, 2013

    Hugh M. O’Brodovich, M.D., Joins AIT’s

    Rehovot, Israel – 17 September 2013 – Israeli biomed company AIT (Advanced Inhalation Therapies Ltd.), a leader in the development …

    Read more

Watch Our video

Nitric Oxide treatment for lung infections and diseases

Read More